HMGB1, neuronal excitability and epilepsy
Open Access
- 30 June 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Acta Epileptologica
- Vol. 3 (1), 1-9
- https://doi.org/10.1186/s42494-021-00048-y
Abstract
Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable neurons. Currently, anti-epileptic drugs remain the main choice to control seizure, but 30% of patients are resistant to the drugs, which calls for more research on new promising targets. Neuroinflammation is closely associated with the development of epilepsy. As an important inflammatory factor, high mobility group protein B1 (HMGB1) has shown elevated expression and an increased proportion of translocation from the nucleus to the cytoplasm in patients with epilepsy and in multiple animal models of epilepsy. HMGB1 can act on downstream receptors such as Toll-like receptor 4 and receptor for advanced glycation end products, thereby activating interleukin (IL)-1β and nuclear factor kappa-B (NF-κB), which in turn act with glutamate receptors such as the N-methyl-D-aspartate (NMDA) receptors to aggravate hyperexcitability and epilepsy. The hyperexcitability can in turn stimulate the expression and translocation of HMGB1. Blocking HMGB1 and its downstream signaling pathways may be a direction for antiepileptic drug therapy. Here, we review the changes of HMGB1-related pathway in epileptic brains and its role in the modulation of neuronal excitability and epileptic seizure. Furthermore, we discuss the potentials of HMGB1 as a therapeutic target for epilepsy and provide perspective on future research on the role of HMGB1 signaling in epilepsy.Keywords
Funding Information
- National Natural Science Foundation of China (81630098, 81973298)
This publication has 66 references indexed in Scilit:
- Neuroprotective effects of anti-high-mobility group box 1 antibody in juvenile rat hippocampus after kainic acid-induced status epilepticusNeuroReport, 2013
- Glycyrrhizin Attenuates Kainic Acid-Induced Neuronal Cell Death in the Mouse HippocampusExperimental Neurobiology, 2013
- Glia and epilepsy: excitability and inflammationTrends in Neurosciences, 2013
- Optogenetic and Potassium Channel Gene Therapy in a Rodent Model of Focal Neocortical EpilepsyScience Translational Medicine, 2012
- Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1Journal of Internal Medicine, 2011
- Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in RatsStroke, 2011
- Inflammasome-Dependent Release of the Alarmin HMGB1 in EndotoxemiaThe Journal of Immunology, 2010
- Endogenous HMGB1 regulates autophagyThe Journal of cell biology, 2010
- High mobility group box‐1 recognition: The beginning of a RAGEless era?EMBO Molecular Medicine, 2010
- NLRP3 (NALP3, Cryopyrin) Facilitates In Vivo Caspase-1 Activation, Necrosis, and HMGB1 Release via Inflammasome-Dependent and -Independent PathwaysThe Journal of Immunology, 2009